Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Histopathology. 2022 Oct;81(4):486-495. doi: 10.1111/his.14564. Epub 2022 Jun 23.
Immunoglobulin 4-related disease (IgG4-RD) is a multisystem disease, characterised by tumefactive lesions and a swift response to immunosuppressive therapy. Although elevated serum and tissue IgG4 are characteristic, T cells appear to be the primary driver of this immunologically mediated disease. The overarching goal was to examine the role of immunomodulatory cells in IgG4-RD.
Biopsies from patients with IgG4-RD (n = 39) and mimics of this disease (n = 78) were evaluated for IgG4, IgG, CD8, programmed cell death ligand 1 (PD-L1) and a subset (n = 18) evaluated for CD4, purine rich box 1 (PU.1), forkhead box protein 3 (FoxP3), PD-L1, programmed cell death 1 (PD-1), indoleamine 2,3-dioxygenase 1 (IDO1) and lymphocyte-activation gene 3 (LAG3). Data pertaining to demographics and laboratory findings at baseline evaluation was extracted from electronic medical records. When compared to mimics, IgG4-RD showed increased numbers of PD-L1- (P = 0.0001), PD-1- (P = 0.001), IDO1- (P = 0.03), LAG3- (P = 0.04) and FoxP3- (P = 0.04)-positive immune cells. The PD-L1-positive cells were enriched within aggregates of CD4 and CD8-positive T cells. Thirty-one of 39 (80%) IgG4-RD cases showed greater than five PD-L1-positive cells per high-power field (HPF), while four of 78 (5%) mimics of this disease exceeded this cut-point. In IgG4-RD, PD-L1-positive macrophages correlated with PD-1- (P = 0.002), LAG3- (P = 0.001) and IDO1-positive cells (P = 0.001); a-positive correlation was also noted between IgG4/IgG ratio and PD-L1-, PD-1- and IDO1-positive cells.
IgG4-RD shows expansion of mechanisms that maintain peripheral tolerance. The spatial and temporal relationship between T cells and the PD-L1-PD-1 axis and the up-regulation of multiple immunomodulatory proteins suggests that these immunoregulatory mechanisms play a significant role in IgG4-RD.
免疫球蛋白 4 相关疾病(IgG4-RD)是一种多系统疾病,其特征为肿块样病变和对免疫抑制治疗的迅速反应。尽管血清和组织中 IgG4 升高是其特征,但 T 细胞似乎是这种免疫介导疾病的主要驱动因素。首要目标是研究免疫调节细胞在 IgG4-RD 中的作用。
对 IgG4-RD 患者(n=39)和该疾病模拟病例(n=78)的活检标本进行 IgG4、IgG、CD8、程序性细胞死亡配体 1(PD-L1)检测,其中一部分(n=18)还进行 CD4、嘌呤盒蛋白 1(PU.1)、叉头框蛋白 3(FoxP3)、PD-L1、程序性细胞死亡 1(PD-1)、吲哚胺 2,3-双加氧酶 1(IDO1)和淋巴细胞激活基因 3(LAG3)检测。从电子病历中提取基线评估时的人口统计学和实验室检查结果数据。与模拟病例相比,IgG4-RD 中 PD-L1-(P=0.0001)、PD-1-(P=0.001)、IDO1-(P=0.03)、LAG3-(P=0.04)和 FoxP3-(P=0.04)阳性免疫细胞的数量增加。PD-L1 阳性细胞富集在 CD4 和 CD8 阳性 T 细胞聚集物内。39 例 IgG4-RD 中有 31 例(80%)每高倍镜视野(HPF)有超过 5 个 PD-L1 阳性细胞,而 78 例模拟病例中仅有 4 例(5%)超过该截点。在 IgG4-RD 中,PD-L1 阳性巨噬细胞与 PD-1-(P=0.002)、LAG3-(P=0.001)和 IDO1-阳性细胞(P=0.001)呈正相关;IgG4/IgG 比值与 PD-L1、PD-1 和 IDO1 阳性细胞也呈正相关。
IgG4-RD 表现出维持外周耐受的机制扩张。T 细胞与 PD-L1-PD-1 轴之间的空间和时间关系以及多种免疫调节蛋白的上调表明,这些免疫调节机制在 IgG4-RD 中发挥了重要作用。